Ferrés-Coy, A
Galofré, M
Pilar-Cuéllar, F
Vidal, R
Paz, V
Ruiz-Bronchal, E
Campa, L
Pazos, Á
Caso, J R
Leza, J C
Alvarado, G
Montefeltro, A
Valdizán, E M
Artigas, F
Bortolozzi, A
Article History
Received: 10 October 2014
Revised: 27 March 2015
Accepted: 6 May 2015
First Online: 23 June 2015
Competing interests
: FA has received consulting and educational honoraria on antidepressant drugs from Lundbeck and he is PI of grants from Lundbeck. He is also a member of the advisory board of Neurolixis Inc. AB and FA are authors of the patent WO/2011/131693 for the siRNA and ASO (antisense oligonucleotides) molecules and the targeting approach related to this work. GA and AM are board members of nLife Therapeutics S.L. The rest of authors declare no competing financial interest.